Trial intelligence / Profile preview

Influence of physical exercise on the aesthetic effect of Botox

RBR-6ms6snsPhase 4Terminated

Sponsor
Uningá
Start
Aug 2022
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, single-blind trial of botulinum toxin type A in Rhytidosis facialis and glabellar furrowing (3 arms), sponsored by Uningá. Started Aug 2022; status: terminated.

02

Drugs

botulinum toxin type A
03

Conditions

Rhytidosis facialisglabellar furrowing

Beyond the preview

Go deeper on RBR-6ms6sns.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6ms6sns.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call